Of time and experience: Sarcoidosis revisited

Chest

Volumn 121, Issue 1, 2002, Pages 3-5

  Miller, Albert ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; STEROID;

CLINICAL TRIAL; COR PULMONALE; EDITORIAL; HEART INDEX; HEART VENTRICLE FUNCTION; HUMAN; LIFE EXPECTANCY; LUNG ARTERY PRESSURE; LUNG FUNCTION; LUNG VASCULAR RESISTANCE; LYMPHADENOPATHY; MORTALITY; PRIORITY JOURNAL; RADIODIAGNOSIS; RELAPSE; REMISSION; SARCOIDOSIS; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 0036157875     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.1.3     Document Type: Editorial

References (12)

1. Extended experience in the long term corticosteroid treatment of pulmonary sarcoidosis
2. Pulmonary function follow-up of 120 patients with sarcoidosis
3. Consensus conference: Activity of sarcoidosis
4. Sarcoidosis
5. American thoracic society statement on sarcoidosis
6. The sequence of physiologic changes in pulmonary sarcoidosis: Correlation with radiographic stages and response to therapy
7. The lesser circulation in pulmonary fibrosis secondary to sarcoidosis and its relationship to respiratory function
8. Right and left ventricular function at rest and with exercise in patients with sarcoidosis
9. Prognosis of chronic sarcoidosis
10. The possible influence of corticosteroid therapy on the natural history of pulmonary sarcoidosis: Late results of a continuing clinical study
11. Corticosteroid therapy in sarcoidosis: A five-year, controlled follow-up study
12. British thoracic society sarcoidosis study: Effects of long term corticosteroid treatment